{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"upside","title":"UP053: emocha // improving medication adherence through remote video observation","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/cb1cdca1\"></iframe>","width":"100%","height":180,"duration":3700,"description":"Interview begins: 08:26 \r\nDebrief begins: 49:12\r\n\r\nSebastian Seiguer is the Co-Founder and CEO of emocha Mobile Health. \r\n\r\nemocha is a mobile health platform that saves lives by connecting remote patients to health care providers. They improve medication adherence using video technology and human engagement. \r\n\r\nemocha leverages a CDC-endorsed model called Directly Observed Therapy (DOT) where healthcare workers watch patients take every dose of medication, monitor side effects, and provide critical support. \r\n\r\nTheir technology is currently used across four continents in 10 countries.\r\n\r\nemocha was founded in 2014 and based in Baltimore, Maryland.\r\n\r\nLearn more about emocha: https://www.emocha.com/\r\nFollow upside on Twitter: https://twitter.com/upsidefm\r\n\r\nVote for upside for the 2020 SXSW Panel Picker: https://upside.fm/vote","thumbnail_url":"https://img.transistorcdn.com/qhlBwGFVyVQpTQUPz91SL_FZ9LxsieuifdWQEs8peZY/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzkxLzE2MDU2MzQx/MjktYXJ0d29yay5q/cGc.webp","thumbnail_width":300,"thumbnail_height":300}